We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

148 hedge funds and large institutions have $1.32B invested in Acorda Therapeutics in 2013 Q2 according to their latest regulatory filings, with 148 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

475% more call options, than puts

Call options by funds: $14.7M | Put options by funds: $2.56M

Holders
148
Holders Change
+148
Holders Change %
–
% of All Funds
4.81%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
148
Increased
–
Reduced
–
Closed
–
Calls
$14.7M
Puts
$2.56M
Net Calls
+$12.2M
Net Calls Change
+$12.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ACOR Hedge Fund Activity: Q2 2013 in Review

148 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q2 2013, worth a combined $1.32B.

Buyers outnumbered sellers: 148 funds opened new ACOR positions and 0 closed out — a net gain of 148 holders — while 0 added to existing stakes and 0 trimmed.

  • 148 institutional investors held Acorda Therapeutics (ACOR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.32B of Acorda Therapeutics stock for Q2 2013.
  • 148 funds opened new Acorda Therapeutics positions in Q2 2013 and 0 closed out, a net change of +148 holders.

Based on aggregated 13F filings for Q2 2013.